Screening compound: MTLFTMCRNVGAOG-SFHVURJKSA-N

Screening compound: MTLFTMCRNVGAOG-SFHVURJKSA-N
Screening compound: MTLFTMCRNVGAOG-SFHVURJKSA-N alternative view

Chemical Structure Depiction of ChemDiv screening compound
MTLFTMCRNVGAOG-SFHVURJKSA-N

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T991-1555

Molecular Formula

C21H27N5O2S (C21 H27 N5 O2 S)

Compound Name

1-(cyclopropylmethyl)-3-{4-[3-(thiophen-2-yl)-1H-pyrazole-5-carbonyl]-1,4-diazepan-1-yl}pyrrolidin-2-one

IUPAC name

1-(cyclopropylmethyl)-3-{4-[3-(thiophen-2-yl)-1H-pyrazole-5-carbonyl]-14-diazepan-1-yl}pyrrolidin-2-one

SMILES

O=C(c1cc(-c2cccs2)n[nH]1)N(CCC1)CCN1C(CCN1CC2CC2)C1=O

InChI

InChI=1S/C21H27N5O2S/c27-20(17-13-16(22-23-17)19-3-1-12-29-19)25-8-2-7-24(10-11-25)18-6-9-26(21(18)28)14-15-4-5-15/h1,3,12-13,15,18H,2,4-11,14H2,(H,22,23)/t18-/m0/s1

InChI Key

MTLFTMCRNVGAOG-SFHVURJKSA-N

MDL Number (MFCD)

MFCD29028883

MTLFTMCRNVGAOG-SFHVURJKSA-N in Drug Discovery

Included in Screening Libraries

3D-Diversity Natural-Product-Like Library (18102 compounds)

3D-Pharmacophore Based Diversity Library (49813 compounds)

Antiviral Library (67538 compounds)

Bcl2-PPI Inhibitors Library (12246 compounds)

GPCR Targeted Library (31838 compounds)

KRAS-Targeted Library (16000 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

SmartTM Library (51161 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
  • Mimetics
  • Mimetics
  • Mimetics
Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Hemic and lymphatic
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
Mechanism of action:
  • PPI modulators
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
Targets:
  • GPCR
  • Kinases

References: we are preparing a list of scientific research reports with MTLFTMCRNVGAOG-SFHVURJKSA-N chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound MTLFTMCRNVGAOG-SFHVURJKSA-N?
Check Price and Availability of MTLFTMCRNVGAOG-SFHVURJKSA-N, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of MTLFTMCRNVGAOG-SFHVURJKSA-N you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for MTLFTMCRNVGAOG-SFHVURJKSA-N
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for MTLFTMCRNVGAOG-SFHVURJKSA-N
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of MTLFTMCRNVGAOG-SFHVURJKSA-N available by request